Q32 Bio (QTTB) Enterprise Value (2017 - 2026)

Q32 Bio's Enterprise Value history runs 10 years deep, the most recent figure standing at -$50.8 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 22.5% year-over-year to -$50.8 million in Q1 2026; TTM through Mar 2026 was -$50.8 million, a 22.5% increase from a year earlier, with the FY2025 full-year figure at -$48.3 million, down 7364.76% from the prior year.
• Enterprise Value retreated to -$50.8 million in Q1 2026 per QTTB's latest filing, from -$48.3 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$647000.0 in Q4 2024 and bottomed at -$256.1 million in Q1 2022.
• The 5-year median for Enterprise Value is -$79.8 million (2023), against an average of -$103.0 million.
• Across the five-year window, Enterprise Value jumped 96.77% in 2023 and plunged 7364.76% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$175.0 million in 2022, then soared by 96.77% to -$5.6 million in 2023, then soared by 88.54% to -$647000.0 in 2024, then plunged by 7364.76% to -$48.3 million in 2025, then retreated by 5.08% to -$50.8 million in 2026.
• Per Business Quant, the three latest QTTB Enterprise Value figures stand at -$50.8 million (Q1 2026), -$48.3 million (Q4 2025), and -$68.9 million (Q3 2025).